Correvio Pharma Corp. operates as a pharmaceutical company. The Company develops and discovers cardiovascular drugs for the treatment of atrial arrhythmia, congestive heart failure, and bacterial skin infections. Correvio Pharma serves patients worldwide.


Pharmaceutical

Correvio Pharma

Correvio Pharma's headquarters in Vancouver, Canada

Mark H. Corrigan

David Mcmasters

Sheila Grant

Justin A. Renz

Hugues Sachot

David Dean

Arthur H. Willms

James O’Shea

Vanda De Cian

Robert James Meyer

William Hunter

Richard M. Glickman

The Board and Executive Oversight team at Correvio Pharma is responsible for strategic governance and high-level decision-making to ensure the company's mission and objectives are met. This team, composed of executive leaders and board members, oversees the development of pharmaceutical products, financial management, compliance, and risk assessment related to the company's operations in the cardiovascular market. Their collaborative efforts drive accountability and align Correvio's initiatives with industry standards and patient needs.

Board and Executive Oversight

The Leadership Team at Correvio Pharma is responsible for setting the strategic direction and overseeing the operations of the company. This team, comprised of executives including the CEO, COO, and CFO, collaboratively drives the development of innovative cardiovascular drugs, ensures regulatory compliance, and fosters partnerships to enhance patient access to therapies, all while managing financial performance and operational efficiency.

Leadership Team

Correvio Pharma

Org chart

Board & advisors

Teams

Board and Executive Oversight

Leadership Team

Offices

Correvio Pharma

Org chart

Board & advisors

Teams

Board and Executive Oversight

Leadership Team

Offices

Related companies